Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol

Özet

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Schering-Plough Animal Health Corp. The supplement provides for changing a pathogen genus from Pasteurella to Mannheimia on labeling of florfenicol injectable solution.